Fund Holdings — Patient Square Capital LP

Total Portfolio Value:
$626.68M
Total Bought:
$99.77M
Total Sold:
$106.07M
Net Transaction:
-$6.30M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Roivant Sciences Ltd.SHS(ROIV)8,020,9287,710,928-310,000$283.86M$281.99M45.00%-$1.87M
Revolution Medicines, Inc.(RVMD)276,000196,000-80,000$51.69M$40.23M6.42%-$11.46M
United Therapeutics Corporation(UTHR)37,12062,677+25,557$20.11M$33.96M5.42%+$13.85M
argenx SEADR(ARGX)23,00028,000+5,000$21.34M$26.85M4.28%+$5.51M
Pharvaris N V
COM
671,209808,644+137,435$23.21M$25.65M4.09%+$2.44M
ABIVAX Société AnonymeADS(ABVX)206,500243,000+36,500$27.52M$24.06M3.84%-$3.46M
Belite Bio, IncADS(BLTE)110,000131,700+21,700$16.94M$22.37M3.57%+$5.43M
Mirum Pharmaceuticals, Inc.(MIRM)260,500234,000-26,500$30.50M$20.00M3.19%-$10.49M
Zai Lab LimitedADR(ZLAB)0591,510+591,510$0$15.58M2.49%+$15.58M
Definium Therapeutics, Inc.(DFTX)0385,000+385,000$0$14.65M2.34%+$14.65M
COMPASS Pathways plcADS(CMPS)01,056,269+1,056,269$0$13.14M2.10%+$13.14M
DBV Technologies S.A.ADS(DBVT)909,4741,105,606+196,132$14.92M$13.00M2.07%-$1.91M
BeOne Medicines AGADS(ONC)90,02033,500-56,520$25.65M$12.26M1.96%-$13.39M
Cogent Biosciences, Inc.(COGT)425,000361,927-63,073$16.45M$11.59M1.85%-$4.86M
Arcus Biosciences, Inc.(RCUS)355,800410,000+54,200$10.97M$10.59M1.69%-$379.0K
BioNTech SEADS(BNTX)134,429105,421-29,008$12.51M$10.36M1.65%-$2.15M
Enliven Therapeutics Inc212,500212,5000$10.78M$9.74M1.55%-$1.04M
Vaxcyte, Inc.(PCVX)0166,000+166,000$0$9.45M1.51%+$9.45M
Kymera Therapeutics, Inc.(KYMR)47,50084,000+36,500$5.45M$9.39M1.50%+$3.94M
Allogene Therapeutics Inc5,050,0004,550,000-500,000$10.50M$7.28M1.16%-$3.22M
Zentalis Pharmaceuticals, Inc.(ZNTL)02,007,485+2,007,485$0$5.56M0.89%+$5.56M
Inventiva S.A.ADS(IVA)1,967,1711,221,225-745,946$7.44M$4.51M0.72%-$2.93M
Harrow, Inc.(HROW)0145,000+145,000$0$4.47M0.71%+$4.47M
Arcutis Biotherapeutics, Inc.(ARQT)370,0000-370,000$9.70M$0—-$9.70M
C4 Therapeutics, Inc.(CCCC)1,608,8150-1,608,815$7.51M$0—-$7.51M
Dianthus Therapeutics, Inc.(DNTH)108,0000-108,000$10.53M$0—-$10.53M
EyePoint, Inc.(EYPT)720,0000-720,000$10.30M$0—-$10.30M
Faeth Therapeutics, Inc.(FTH)175,0500-175,050$4.38M$0—-$4.38M
Xenon Pharmaceuticals Inc.(XENE)220,0000-220,000$13.28M$0—-$13.28M
Page 1 of 1
Patient Square Capital LP — 13F Holdings — Q3 2026 | TickerTrail